共 117 条
[1]
Smith JA(1992)kappa-Opioid inhibition of [ Mol Pharmacol 42 575-83
[2]
Loughlin SE(2006)H]dopamine release from rat ventral mesencephalic dissociated cell cultures. Eur J Neurosci 23 229-38
[3]
Leslie FM(2005)Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neu-rotransmission in the nucleus accumbens. Exp Neurol 191 41-52
[4]
Chefer VI(2003)The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neurons. J Neurosci 23 9981-6
[5]
Shippenberg TS(1998)kappa-Opioid agonists directly inhibit midbrain dopaminergic neurons. J Med Chem 41 4911-4
[6]
Marin C(1990)Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors. Life Sci 46 PL1-7
[7]
Bove J(1990)PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats. Eur J Pharmacol 191 477-80
[8]
Serrats J(1993)The anticonvulsant action of CI-977, a selective kappa-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex. Gen Pharmacol 24 439-47
[9]
Cortes R(1999)Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex. Life Sci 65 857-62
[10]
Mengod G(1991)Characterization of kappa 1-opioid receptor binding in human insular cortex. J Neurosci Methods 36 145-53